本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Viking Therapeutics, Inc.

31.26
+0.56001.82%
成交量:167.41万
成交额:5,256.64万
市值:35.11亿
市盈率:-27.10
高:31.94
开:31.25
低:30.67
收:30.70
数据加载中...
2024/02/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/07

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/07

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/07

重要事件披露

Form 8-K - Current report
2024/02/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/02

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/10/26

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/25

重要事件披露

Form 8-K - Current report
2023/07/27

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/07/26

重要事件披露

Form 8-K - Current report
2023/06/15

重要事件披露

Form 8-K - Current report
2023/05/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/05/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/05/11

重要事件披露

8-K - Current report
2023/05/01

关联方拟减持公告

144 - Report of proposed sale of securities